Loading...

Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency

Clinical trials of bone marrow mesenchymal stem cell (MSC) therapy have thus far demonstrated moderate and inconsistent benefits, indicating an urgent need to improve therapeutic efficacy. Although administration of sufficient cells is necessary to achieve maximal therapeutic benefits, documented MS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Mastri, Michalis, Shah, Zaeem, McLaughlin, Terence, Greene, Christopher J., Baum, Leah, Suzuki, Gen, Lee, Techung
Format: Artigo
Sprog:Inglês
Udgivet: American Physiological Society 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3492833/
https://ncbi.nlm.nih.gov/pubmed/22843797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00191.2012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!